PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 152 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,478,000 | +43.2% | 318,477 | +29.6% | 0.00% | +100.0% |
| Q4 2018 | $1,032,000 | -65.9% | 245,666 | -49.2% | 0.00% | -50.0% |
| Q3 2018 | $3,030,000 | +66.8% | 483,310 | +113.9% | 0.00% | 0.0% |
| Q2 2018 | $1,817,000 | +11.3% | 225,959 | +3.3% | 0.00% | 0.0% |
| Q1 2018 | $1,633,000 | +25.6% | 218,843 | +0.2% | 0.00% | 0.0% |
| Q4 2017 | $1,300,000 | -14.6% | 218,468 | +5.6% | 0.00% | 0.0% |
| Q3 2017 | $1,522,000 | +9.1% | 206,854 | +0.7% | 0.00% | 0.0% |
| Q2 2017 | $1,395,000 | +22.7% | 205,501 | +70.6% | 0.00% | 0.0% |
| Q1 2017 | $1,137,000 | +17.6% | 120,479 | +7.6% | 0.00% | 0.0% |
| Q4 2016 | $967,000 | +39.9% | 111,935 | +2.5% | 0.00% | +100.0% |
| Q3 2016 | $691,000 | +49.9% | 109,166 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $461,000 | +3.8% | 109,166 | +7.3% | 0.00% | 0.0% |
| Q1 2016 | $444,000 | -28.8% | 101,724 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $624,000 | +7.2% | 101,724 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $582,000 | -23.3% | 101,724 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $759,000 | +24.8% | 101,724 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $608,000 | -20.9% | 101,724 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $769,000 | +45.6% | 101,724 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $528,000 | +20.5% | 101,724 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $438,000 | -2.7% | 101,724 | -7.5% | 0.00% | 0.0% |
| Q1 2014 | $450,000 | +8.2% | 109,938 | +40.8% | 0.00% | 0.0% |
| Q4 2013 | $416,000 | +10.6% | 78,108 | +4.4% | 0.00% | 0.0% |
| Q3 2013 | $376,000 | +31.9% | 74,828 | +17.0% | 0.00% | 0.0% |
| Q2 2013 | $285,000 | – | 63,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|